The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Aromathecins are inhibitors of human topoisomerase I (Top1). These compounds are composites of several heteroaromatic systems, namely the camptothecins and indenoisoquinolines, and they possess notable Top1 inhibition and cytotoxicity when substituted at position 14. The SAR of these compounds overlaps with indenoisoquinolines, suggesting that they may intercalate into the Top1-DNA complex similarly. Nonetheless, the proposed binding mode for aromathecins is purely hypothetical, as an X-ray structure is unavailable. In the present communication, we have synthesized eight novel series of A-ring-substituted (positions 1-3) aromathecins, through a simple, modular route, as part of a comprehensive SAR study. Certain groups (such as 2,3-ethylenedioxy) moderately improve Top1 inhibition, and, often, antiproliferative activity, whereas other groups (2,3-dimethoxy and 3-substituents) attenuate bioactivity. Strikingly, these trends are very similar to those previously observed for the A-ring of camptothecins, and this considerable SAR overlap lends further support (in the absence of crystallographic data) to the hypothesis that aromathecins bind in the Top1 cleavage complex as interfacial inhibitors in a 'camptothecin-like' pose.

Knowledge Graph

Similar Paper

The structure–activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode
Bioorganic & Medicinal Chemistry 2010.0
Synthesis and biological evaluation of 14-(aminoalkyl-aminomethyl)aromathecins as topoisomerase I inhibitors: Investigating the hypothesis of shared structure–activity relationships
Bioorganic & Medicinal Chemistry 2009.0
Design, Synthesis, and Biological Evaluation of 14-Substituted Aromathecins as Topoisomerase I Inhibitors
Journal of Medicinal Chemistry 2008.0
Synthesis and Anticancer Activity of Simplified Indenoisoquinoline Topoisomerase I Inhibitors Lacking Substituents on the Aromatic Rings
Journal of Medicinal Chemistry 2004.0
Nitrated Indenoisoquinolines as Topoisomerase I Inhibitors:  A Systematic Study and Optimization
Journal of Medicinal Chemistry 2007.0
Optimization of the Indenone Ring of Indenoisoquinoline Topoisomerase I Inhibitors
Journal of Medicinal Chemistry 2007.0
Synthesis of New Indeno[1,2-c]isoquinolines:  Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors
Journal of Medicinal Chemistry 2000.0
3-Arylisoquinolines as novel topoisomerase I inhibitors
Bioorganic & Medicinal Chemistry 2011.0
Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents
European Journal of Medicinal Chemistry 2012.0
The synthesis of 5-substituted camptothecins as potential inhibitors of DNA topoisomerase I
Bioorganic & Medicinal Chemistry Letters 1995.0